(Total Views: 376)
Posted On: 06/07/2019 1:27:47 PM
Post# of 145915
![](/m/assets/46931549/no_avatar_available_thumb.jpg)
Today interview :..,
0:35 FDA want to meet with us to talk about pivotal , what is a rationale for our 525 to 700 mg.
( I have a feeling FDA think only 525 is enough )
1:19 final design of pivotal and we meet with them.
2:25 we have potential to have partnership and licensing with pharmaceutical we work in USA right now .
2:35 pivotal to start in the next couple months
2:50 talking about prevention
3:20 CCR5 antagonists is A TALK NOW about HIV cure and prevention .
TO doing well....
0:35 FDA want to meet with us to talk about pivotal , what is a rationale for our 525 to 700 mg.
( I have a feeling FDA think only 525 is enough )
1:19 final design of pivotal and we meet with them.
2:25 we have potential to have partnership and licensing with pharmaceutical we work in USA right now .
2:35 pivotal to start in the next couple months
2:50 talking about prevention
3:20 CCR5 antagonists is A TALK NOW about HIV cure and prevention .
TO doing well....
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)